カテゴリー： Transparency Market Research, 世界, 医療/バイオ

神経血管デバイスの世界市場（2023～2033）：デバイス種類別、治療用途別、地域別

◆英語タイトル：Global Neurovascular Devices Market by Device Type (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices), by Therapeutic Application (Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm, Other Therapeutic Applications) and Region - 2023 to 2033

Transparency Market Researchが発行した調査報告書（TMR23AP091）◆商品コード：TMR23AP091
◆発行会社（リサーチ会社）：Transparency Market Research
◆発行日：2023年1月9日
◆ページ数：250
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥869,250見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,319,250見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,769,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社の本調査レポートでは、神経血管デバイスの世界市場について総合的に分析し、今後の市場動向を予測しています。本書は、エグゼクティブサマリー、市場概要、市場背景、市場分析＆予測、デバイス種類別（脳塞栓＆動脈瘤コイリング装置、脳血管形成＆ステント装置、神経血栓除去装置、サポート装置）分析、治療用途別（脳卒中、脳動脈狭窄症、脳動脈瘤、その他）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、市場構造分析、競争分析などの項目が整理されています。また、本書内には、Medtronic、Microport Scientific Corporation、Penumbra Inc、Stryker、Johnson & Johnson Services Inc.、Microvention Inc.、Codman Neuroなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場概要
・市場背景
・市場分析＆予測
・世界の神経血管デバイス市場規模：デバイス種類別
- 脳塞栓＆動脈瘤コイリング装置の市場規模
- 脳血管形成＆ステント装置の市場規模
- 神経血栓除去装置の市場規模
- サポート装置の市場規模
・世界の神経血管デバイス市場規模：治療用途別
- 脳卒中における市場規模
- 脳動脈狭窄症における市場規模
- 脳動脈瘤における市場規模
- その他治療用途における市場規模
・世界の神経血管デバイス市場規模：地域別
- 北米の神経血管デバイス市場規模
- ヨーロッパの神経血管デバイス市場規模
- アジア太平洋の神経血管デバイス市場規模
- 中東・アフリカの神経血管デバイス市場規模
- 中南米の神経血管デバイス市場規模
・市場構造分析
・競争分析

Neurovascular Devices Market – Scope of Report
TMR’s report on the global neurovascular devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global neurovascular devices market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global neurovascular devices market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the neurovascular devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global neurovascular devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global neurovascular devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global neurovascular devices market.

The report delves into the competitive landscape of the global neurovascular devices market. Key players operating in the global neurovascular devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global neurovascular devices market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market neurovascular devices.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

• Industry Sources:
o WorldWideScience.org
o Elsevier, Inc.
o National Institutes of Health (NIH)
o PubMed
o NCBI
o Department of Health Care Service
• Trade Data Sources
o Trade Map
o UN Comtrade
o Trade Atlas
• Company Information
o OneSource Business Browser
o Hoover’s
o Factiva
o Bloomberg
• Mergers & Acquisitions
o Thomson Mergers & Acquisitions
o MergerStat
o Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

❖ レポートの目次 ❖

1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity 
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Product Life Cycle Analysis
    3.5. Supply Chain Analysis
        3.5.1. Supply Side Participants and their Roles
            3.5.1.1. Producers
            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
            3.5.1.3. Wholesalers and Distributors
        3.5.2. Value Added and Value Created at Node in the Supply Chain
        3.5.3. List of Raw Material Suppliers
        3.5.4. List of Existing and Potential Buyer’s
    3.6. Investment Feasibility Matrix
    3.7. Value Chain Analysis
        3.7.1. Profit Margin Analysis
        3.7.2. Wholesalers and Distributors
        3.7.3. Retailers
    3.8. PESTLE and Porter’s Analysis
    3.9. Regulatory Landscape
        3.9.1. By Key Regions
        3.9.2. By Key Countries
    3.10. Regional Parent Market Outlook
    3.11. Production and Consumption Statistics
    3.12. Import and Export Statistics
4. Global Neurovascular Devices Market Analysis 2018-2022 and Forecast, 2023-2033
    4.1. Historical Market Size Value (US$ Bn) & Volume (Units) Analysis, 2018-2022
    4.2. Current and Future Market Size Value (US$ Bn) & Volume (Units) Projections, 2023-2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Device Type
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Bn) & Volume (Units) Analysis By Device Type, 2018-2022
    5.3. Current and Future Market Size Value (US$ Bn) & Volume (Units) Analysis and Forecast By Device Type, 2023-2033
        5.3.1. Cerebral Embolization and Aneurysm Coiling Devices
            5.3.1.1. Embolic Coils
            5.3.1.2. Flow Diversion Devices
            5.3.1.3. Liquid Embolic Agents
        5.3.2. Cerebral Angioplasty and Stenting Systems
            5.3.2.1. Carotid Artery Stents
            5.3.2.2. Embolic protection
        5.3.3. Neurothrombectomy Devices
            5.3.3.1. Clot Retrieval Devices
            5.3.3.2. Suction Devices
            5.3.3.3. Vascular Snares
        5.3.4. Support Devices
            5.3.4.1. Micro Catheters
            5.3.4.2. Micro Guidewires
    5.4. Y-o-Y Growth Trend Analysis By Device Type, 2018-2022
    5.5. Absolute $ Opportunity Analysis By Device Type, 2023-2033
6. Global Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Therapeutic Application
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Bn) & Volume (Units) Analysis By Therapeutic Application, 2018-2022
    6.3. Current and Future Market Size Value (US$ Bn) & Volume (Units) Analysis and Forecast By Therapeutic Application, 2023-2033
        6.3.1. Stroke
            6.3.1.1. Cerebral Artery Stenosis
            6.3.1.2. Cerebral Aneurysm
            6.3.1.3. Other Therapeutic Applications
        6.3.2. Cerebral Artery Stenosis
        6.3.3. Cerebral Aneurysm
        6.3.4. Other Therapeutic Applications
    6.4. Y-o-Y Growth Trend Analysis By Therapeutic Application, 2018-2022
    6.5. Absolute $ Opportunity Analysis By Therapeutic Application, 2023-2033
7. Global Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Region
    7.1. Introduction
    7.2. Historical Market Size Value (US$ Bn) & Volume (Units) Analysis By Region, 2018-2022
    7.3. Current Market Size Value (US$ Bn) & Volume (Units) Analysis and Forecast By Region, 2023-2033
        7.3.1. North America
        7.3.2. Latin America
        7.3.3. Europe
        7.3.4. Asia Pacific
        7.3.5. MEA
    7.4. Market Attractiveness Analysis By Region
8. North America Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    8.1. Historical Market Size Value (US$ Bn) & Volume (Units) Trend Analysis By Market Taxonomy, 2018-2022
    8.2. Market Size Value (US$ Bn) & Volume (Units) Forecast By Market Taxonomy, 2023-2033
        8.2.1. By Country
            8.2.1.1. Value (US$ Bn) & Volume (Units)ed States
            8.2.1.2. Canada
        8.2.2. By Device Type
        8.2.3. By Therapeutic Application
    8.3. Market Attractiveness Analysis
        8.3.1. By Country
        8.3.2. By Device Type
        8.3.3. By Therapeutic Application
    8.4. Key Takeaways
9. Latin America Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    9.1. Historical Market Size Value (US$ Bn) & Volume (Units) Trend Analysis By Market Taxonomy, 2018-2022
    9.2. Market Size Value (US$ Bn) & Volume (Units) Forecast By Market Taxonomy, 2023-2033
        9.2.1. By Country
            9.2.1.1. Brazil
            9.2.1.2. Mexico
            9.2.1.3. Rest of Latin America
        9.2.2. By Device Type
        9.2.3. By Therapeutic Application
    9.3. Market Attractiveness Analysis
        9.3.1. By Country
        9.3.2. By Device Type
        9.3.3. By Therapeutic Application
    9.4. Key Takeaways
10. Europe Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    10.1. Historical Market Size Value (US$ Bn) & Volume (Units) Trend Analysis By Market Taxonomy, 2018-2022
    10.2. Market Size Value (US$ Bn) & Volume (Units) Forecast By Market Taxonomy, 2023-2033
        10.2.1. By Country
            10.2.1.1. Germany
            10.2.1.2. U.K.
            10.2.1.3. France
            10.2.1.4. Spain
            10.2.1.5. Italy
            10.2.1.6. Russia
            10.2.1.7. Rest of Europe
        10.2.2. By Device Type
        10.2.3. By Therapeutic Application
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Device Type
        10.3.3. By Therapeutic Application
    10.4. Key Takeaways
11. Asia Pacific Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    11.1. Historical Market Size Value (US$ Bn) & Volume (Units) Trend Analysis By Market Taxonomy, 2018-2022
    11.2. Market Size Value (US$ Bn) & Volume (Units) Forecast By Market Taxonomy, 2023-2033
        11.2.1. By Country
            11.2.1.1. China
            11.2.1.2. Japan
            11.2.1.3. India
            11.2.1.4. South Korea
            11.2.1.5. Australia
            11.2.1.6. Rest of APAC
        11.2.2. By Device Type
        11.2.3. By Therapeutic Application
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Device Type
        11.3.3. By Therapeutic Application
    11.4. Key Takeaways
12. MEA Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    12.1. Historical Market Size Value (US$ Bn) & Volume (Units) Trend Analysis By Market Taxonomy, 2018-2022
    12.2. Market Size Value (US$ Bn) & Volume (Units) Forecast By Market Taxonomy, 2023-2033
        12.2.1. By Country
            12.2.1.1. South Africa
            12.2.1.2. Saudi Arabia
            12.2.1.3. UAE
            12.2.1.4. Israel
            12.2.1.5. Rest of MEA
        12.2.2. By Device Type
        12.2.3. By Therapeutic Application
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Device Type
        12.3.3. By Therapeutic Application
    12.4. Key Takeaways
13. Key Countries Neurovascular Devices Market Analysis
    13.1. Value (US$ Bn) & Volume (Units)ed States
        13.1.1. Pricing Analysis
        13.1.2. Market Share Analysis, 2022
            13.1.2.1. By Device Type
            13.1.2.2. By Therapeutic Application
    13.2. Canada
        13.2.1. Pricing Analysis
        13.2.2. Market Share Analysis, 2022
            13.2.2.1. By Device Type
            13.2.2.2. By Therapeutic Application
    13.3. Brazil
        13.3.1. Pricing Analysis
        13.3.2. Market Share Analysis, 2022
            13.3.2.1. By Device Type
            13.3.2.2. By Therapeutic Application
    13.4. Mexico
        13.4.1. Pricing Analysis
        13.4.2. Market Share Analysis, 2022
            13.4.2.1. By Device Type
            13.4.2.2. By Therapeutic Application
    13.5. Germany
        13.5.1. Pricing Analysis
        13.5.2. Market Share Analysis, 2022
            13.5.2.1. By Device Type
            13.5.2.2. By Therapeutic Application
    13.6. U.K.
        13.6.1. Pricing Analysis
        13.6.2. Market Share Analysis, 2022
            13.6.2.1. By Device Type
            13.6.2.2. By Therapeutic Application
    13.7. France
        13.7.1. Pricing Analysis
        13.7.2. Market Share Analysis, 2022
            13.7.2.1. By Device Type
            13.7.2.2. By Therapeutic Application
    13.8. Spain
        13.8.1. Pricing Analysis
        13.8.2. Market Share Analysis, 2022
            13.8.2.1. By Device Type
            13.8.2.2. By Therapeutic Application
    13.9. Italy
        13.9.1. Pricing Analysis
        13.9.2. Market Share Analysis, 2022
            13.9.2.1. By Device Type
            13.9.2.2. By Therapeutic Application
    13.10. Russia
        13.10.1. Pricing Analysis
        13.10.2. Market Share Analysis, 2022
            13.10.2.1. By Device Type
            13.10.2.2. By Therapeutic Application
    13.11. China
        13.11.1. Pricing Analysis
        13.11.2. Market Share Analysis, 2022
            13.11.2.1. By Device Type
            13.11.2.2. By Therapeutic Application
    13.12. Japan
        13.12.1. Pricing Analysis
        13.12.2. Market Share Analysis, 2022
            13.12.2.1. By Device Type
            13.12.2.2. By Therapeutic Application
    13.13. India
        13.13.1. Pricing Analysis
        13.13.2. Market Share Analysis, 2022
            13.13.2.1. By Device Type
            13.13.2.2. By Therapeutic Application
    13.14. South Korea
        13.14.1. Pricing Analysis
        13.14.2. Market Share Analysis, 2022
            13.14.2.1. By Device Type
            13.14.2.2. By Therapeutic Application
    13.15. Australia
        13.15.1. Pricing Analysis
        13.15.2. Market Share Analysis, 2022
            13.15.2.1. By Device Type
            13.15.2.2. By Therapeutic Application
    13.16. South Africa
        13.16.1. Pricing Analysis
        13.16.2. Market Share Analysis, 2022
            13.16.2.1. By Device Type
            13.16.2.2. By Therapeutic Application
    13.17. Saudi Arabia
        13.17.1. Pricing Analysis
        13.17.2. Market Share Analysis, 2022
            13.17.2.1. By Device Type
            13.17.2.2. By Therapeutic Application
    13.18. UAE
        13.18.1. Pricing Analysis
        13.18.2. Market Share Analysis, 2022
            13.18.2.1. By Device Type
            13.18.2.2. By Therapeutic Application
    13.19. Israel
        13.19.1. Pricing Analysis
        13.19.2. Market Share Analysis, 2022
            13.19.2.1. By Device Type
            13.19.2.2. By Therapeutic Application
14. Market Structure Analysis
    14.1. Competition Dashboard
    14.2. Competition Benchmarking
    14.3. Market Share Analysis of Top Players
        14.3.1. By Regional
        14.3.2. By Device Type
        14.3.3. By Therapeutic Application
15. Competition Analysis
    15.1. Competition Deep Dive
        15.1.1. Medtronic
            15.1.1.1. Overview
            15.1.1.2. Product Portfolio
            15.1.1.3. Profitability by Market Segments
            15.1.1.4. Sales Footprint
            15.1.1.5. Strategy Overview
                15.1.1.5.1. Marketing Strategy
                15.1.1.5.2. Product Strategy
                15.1.1.5.3. Channel Strategy
        15.1.2. Microport Scientific Corporation
            15.1.2.1. Overview
            15.1.2.2. Product Portfolio
            15.1.2.3. Profitability by Market Segments
            15.1.2.4. Sales Footprint
            15.1.2.5. Strategy Overview
                15.1.2.5.1. Marketing Strategy
                15.1.2.5.2. Product Strategy
                15.1.2.5.3. Channel Strategy
        15.1.3. Penumbra Inc
            15.1.3.1. Overview
            15.1.3.2. Product Portfolio
            15.1.3.3. Profitability by Market Segments
            15.1.3.4. Sales Footprint
            15.1.3.5. Strategy Overview
                15.1.3.5.1. Marketing Strategy
                15.1.3.5.2. Product Strategy
                15.1.3.5.3. Channel Strategy
        15.1.4. Stryker
            15.1.4.1. Overview
            15.1.4.2. Product Portfolio
            15.1.4.3. Profitability by Market Segments
            15.1.4.4. Sales Footprint
            15.1.4.5. Strategy Overview
                15.1.4.5.1. Marketing Strategy
                15.1.4.5.2. Product Strategy
                15.1.4.5.3. Channel Strategy
        15.1.5. Johnson & Johnson Services Inc
            15.1.5.1. Overview
            15.1.5.2. Product Portfolio
            15.1.5.3. Profitability by Market Segments
            15.1.5.4. Sales Footprint
            15.1.5.5. Strategy Overview
                15.1.5.5.1. Marketing Strategy
                15.1.5.5.2. Product Strategy
                15.1.5.5.3. Channel Strategy
        15.1.6. MicroVention, Inc.
            15.1.6.1. Overview
            15.1.6.2. Product Portfolio
            15.1.6.3. Profitability by Market Segments
            15.1.6.4. Sales Footprint
            15.1.6.5. Strategy Overview
                15.1.6.5.1. Marketing Strategy
                15.1.6.5.2. Product Strategy
                15.1.6.5.3. Channel Strategy
        15.1.7. Integra LifeSciences Corporation
            15.1.7.1. Overview
            15.1.7.2. Product Portfolio
            15.1.7.3. Profitability by Market Segments
            15.1.7.4. Sales Footprint
            15.1.7.5. Strategy Overview
                15.1.7.5.1. Marketing Strategy
                15.1.7.5.2. Product Strategy
                15.1.7.5.3. Channel Strategy
16. Assumptions & Acronyms Used
17. Research Methodology

List of Tables

Table 1: Global Neurovascular Devices Market Value (US$ Bn) Forecast by Region, 2018-2033

Table 2: Global Neurovascular Devices Market Volume (Units) Forecast by Region, 2018-2033

Table 3: Global Neurovascular Devices Market Value (US$ Bn) Forecast by Device Type, 2018-2033

Table 4: Global Neurovascular Devices Market Volume (Units) Forecast by Device Type, 2018-2033

Table 5: Global Neurovascular Devices Market Value (US$ Bn) Forecast by Therapeutic Application, 2018-2033

Table 6: Global Neurovascular Devices Market Volume (Units) Forecast by Therapeutic Application, 2018-2033

Table 7: North America Neurovascular Devices Market Value (US$ Bn) Forecast by Country, 2018-2033

Table 8: North America Neurovascular Devices Market Volume (Units) Forecast by Country, 2018-2033

Table 9: North America Neurovascular Devices Market Value (US$ Bn) Forecast by Device Type, 2018-2033

Table 10: North America Neurovascular Devices Market Volume (Units) Forecast by Device Type, 2018-2033

Table 11: North America Neurovascular Devices Market Value (US$ Bn) Forecast by Therapeutic Application, 2018-2033

Table 12: North America Neurovascular Devices Market Volume (Units) Forecast by Therapeutic Application, 2018-2033

Table 13: Latin America Neurovascular Devices Market Value (US$ Bn) Forecast by Country, 2018-2033

Table 14: Latin America Neurovascular Devices Market Volume (Units) Forecast by Country, 2018-2033

Table 15: Latin America Neurovascular Devices Market Value (US$ Bn) Forecast by Device Type, 2018-2033

Table 16: Latin America Neurovascular Devices Market Volume (Units) Forecast by Device Type, 2018-2033

Table 17: Latin America Neurovascular Devices Market Value (US$ Bn) Forecast by Therapeutic Application, 2018-2033

Table 18: Latin America Neurovascular Devices Market Volume (Units) Forecast by Therapeutic Application, 2018-2033

Table 19: Europe Neurovascular Devices Market Value (US$ Bn) Forecast by Country, 2018-2033

Table 20: Europe Neurovascular Devices Market Volume (Units) Forecast by Country, 2018-2033

Table 21: Europe Neurovascular Devices Market Value (US$ Bn) Forecast by Device Type, 2018-2033

Table 22: Europe Neurovascular Devices Market Volume (Units) Forecast by Device Type, 2018-2033

Table 23: Europe Neurovascular Devices Market Value (US$ Bn) Forecast by Therapeutic Application, 2018-2033

Table 24: Europe Neurovascular Devices Market Volume (Units) Forecast by Therapeutic Application, 2018-2033

Table 25: Asia Pacific Neurovascular Devices Market Value (US$ Bn) Forecast by Country, 2018-2033

Table 26: Asia Pacific Neurovascular Devices Market Volume (Units) Forecast by Country, 2018-2033

Table 27: Asia Pacific Neurovascular Devices Market Value (US$ Bn) Forecast by Device Type, 2018-2033

Table 28: Asia Pacific Neurovascular Devices Market Volume (Units) Forecast by Device Type, 2018-2033

Table 29: Asia Pacific Neurovascular Devices Market Value (US$ Bn) Forecast by Therapeutic Application, 2018-2033

Table 30: Asia Pacific Neurovascular Devices Market Volume (Units) Forecast by Therapeutic Application, 2018-2033

Table 31: MEA Neurovascular Devices Market Value (US$ Bn) Forecast by Country, 2018-2033

Table 32: MEA Neurovascular Devices Market Volume (Units) Forecast by Country, 2018-2033

Table 33: MEA Neurovascular Devices Market Value (US$ Bn) Forecast by Device Type, 2018-2033

Table 34: MEA Neurovascular Devices Market Volume (Units) Forecast by Device Type, 2018-2033

Table 35: MEA Neurovascular Devices Market Value (US$ Bn) Forecast by Therapeutic Application, 2018-2033

Table 36: MEA Neurovascular Devices Market Volume (Units) Forecast by Therapeutic Application, 2018-2033

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 神経血管デバイスの世界市場（2023～2033）：デバイス種類別、治療用途別、地域別(Global Neurovascular Devices Market by Device Type (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices), by Therapeutic Application (Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm, Other Therapeutic Applications) and Region - 2023 to 2033)]についてメールでお問い合わせはこちらでお願いします。
グローバルリサーチ調査資料のイメージグローバルリサーチ調査資料のイメージ
◆関連リサーチレポート◆
  • 世界のディスプレイポートアダプタ市場（2023-2033）：種類別（USB-C、ディスプレイポート、HDMI、サンダーボルト、VGA、DVI）、ポート種類別（シングルディスプレイアダプタ、マルチディスプレイアダプタ、マルチポートアダプタ）、デバイス種類別（コンピュータ/デスクトップ、ノートパソコン、電話機/タブレット、テレビ、プロジェクタ、モニタ）、販売チャネル別（オンライン、オフライン）、エンドユース別（住宅/個人、商業、産業/製造、政府/公共部門）、地域別
  • 世界の伸縮梯子市場（2023-2033）：種類別（ロープ式伸縮梯子、伸縮梯子、組合せ梯子）、材料別（アルミニウム、ガラス繊維、その他）、用途別（産業用、商業用、住宅用）、地域別
  • 世界の自動車用ヒーターコア市場（2023-2033）：車種別（乗用車、LCV、HCV、電気自動車）、材質別（アルミニウム、銅/真鍮）、エンジン種類別（ガソリン、ディーゼル、CNG、電気）、幅別（4〜7インチ、7. 1～10インチ、 10インチ以上)、 インレット/アウトレット種類別 (0.75インチ、 0.62インチ、 0.56インチ、 Oリング、 フランジ)、 販売チャネル別 (OEM、 アフターマーケット)、 地域別
  • 世界のガーネット市場（2023-2033）：製品種類別（アルマンディン、アンドラダイト、グロシュラー、パイロープ、スペサルティン、ウバロバイト）、用途別（ウォータージェットカッティング、研磨ブラスト、浄水器、研磨パウダー、その他）、地域別
  • 世界の家庭用ロボット掃除機市場（2023-2033）：ロボット種類別（屋外ロボット、家庭内ロボット[ハイエンド、ミッドレンジ、ローエンド]）、充電モード別（手動充電、自動バッテリー充電）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆